“…However, IgM + MBCs were also enriched for many genes proposed to regulate or inhibit B cell activation, such as FCRLA, FCRL2, FCRL3, CBLB, CD72 and SIGLEC10 (Wu and Bondada, 2009, Sohn et al, 2003, Meyer et al, 2018, Kochi et al, 2009, Shabani et al, 2014), which may reflect a fine regulatory balance controlling their activation threshold. Perhaps underpinning this, unswitched MBCs also expressed higher levels of the transcription factor genes POU2F2 (OCT2) and FOXP1 than class-switched MBCs (Figure 5F), which coordinate the capacity of B cells to respond normally to antigen receptor signals and directly repress key regulators of plasma cell differentiation respectively (van Keimpema et al, 2015, Corcoran et al, 2014). This is consistent with switched IgG + MBCs being more likely to differentiate into plasma cells, while unswitched IgM + MBCs are more likely to re-enter or form secondary GC responses to gain higher affinity (Dogan et al, 2009, Lutz et al, 2015, Seifert et al, 2015).…”